Skip to main content

Table 1 MAPK7 gene amplification prevalence in Chinese NSCLC and sqEC

From: Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma

Tumor types

MAPK7 AMP prevalence

NSCLC

4 % (3/74) (enriched to 3/49 in squamous cell lung)

sqEC

2 % (2/95)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us